Search

A graphical representation of the activities of porous scaffolds designed based on a dual-aperture (mesoporous and macroporous) system loaded with cell-free fat extract.

Injured bone regeneration requires a systemically and carefully orchestrated series of events involving inflammation, angiogenesis, and osteogenesis. Thus, we designed a multifunctional cell-supporting and drug-retarding dual-pore system: cell-free fat extract (Ceffe)-mesoporous silica nanoparticle (MSN)@poly(lactic

The transformation of microglia to a pro-inflammatory phenotype at the site of traumatic brain injury (TBI) drives the progression of secondary neurodegeneration and irreversible neurological impairment. Omega-3 polyunsaturated fatty acids (PUFAs) have been shown to suppress this phenotype transformation, thereby reducing neuroinflammation following TBI, but the molecular mechanisms are unknown. We found that Omega-3 PUFA suppressed the expression of disintegrin metalloproteinase (ADAM17), the enzyme required to convert tumor necrosis factor-a (TNF-α) to the soluble form, thereby inhibiting the TNF-α/NF-κB pathway both in vitro and in a mouse model of TBI. Omega-3 PUFA also prevented the reactive transformation of microglia and promoted the secretion of microglial exosomes containing nerve growth factor (NGF), activating the neuroprotective NGF/TrkA pathway both in culture and TBI model mice. Moreover, Omega-3 PUFA suppressed the pro-apoptotic NGF/P75NTR pathway at the TBI site and reduced apoptotic neuronal death, brain edema, and disruption of the blood–brain barrier. Finally, Omega-3 PUFA preserved sensory and motor function as assessed by two broad-spectrum test batteries. The beneficial effects of Omega-3 PUFA were blocked by an ADAM17 promotor and by a NGF inhibitor, confirming the pathogenic function of ADAM17 and the central neuroprotective role of NGF. Collectively, these findings provide a strong experimental basis for Omega-3 PUFA as a potential clinical treatment for TBI.

Glioma is a neural malignant tumor that resistant to radiotherapy and chemotherapy, for which surgery is a challenge due to the unclear boundary between glioma tissues and normal brain tissues. Radiofrequency ablation (RFA) is a substitute technology of surgery widely applied in the treatment of solid malignant tumors. However, recently researches indicate that the progression of hepatocellular carcinoma can be facilitated RFA. The present study aims to check whether the progression of glioma can be facilitated by RFA and investigate the underlying mechanism. The sublethal heat, which is regularly detected in the marginal zones of RFA treatments, was utilized to mimic the effects of RFA on glioma cells. Firstly, we found that the 50℃ was the optimized condition in U251 cells and SNB19 cells, which was verified by increased MTT absorbance, promoted invaded cells, accelerated cell cycle, increased clone formation, and faster growth rate in xenograft animals. Subsequently, P300 was found dramatically upregulated in 50℃ treated glioma cells, the progression of which was abolished by the knockdown of P300. Survival analysis revealed that longer survival was observed in P300 knockdown glioma cells. Furthermore, the expression level of β-catenin and its several target genes were positively correlated with P300. TGF-β promoter could be precipitated by the antibody of both P300 and β-catenin in P300-overexpressed glioma cells. Additionally, NF-κB p65 level in the nucleus was positively correlated with P300 and p-IκB was significantly upregulated under the stimulation of the sublethal heat treatment, while the effects of sublethal heat treatment on glioma cells were abolished by the mutation of IκB. P300 was identified to be regulated by NF-κB in a transcriptional level. Lastly, we found that P300 was upregulated in RFA treated patients and RFA induced a shorten overall survival. Collectively, our data implied that sublethal heat treatment facilitated the progression of glioma by recruiting the β-catenin pathway through regulating the NF-κB/P300 axis.

Subarachnoid hemorrhage (SAH) as a devastating neurological disorder is closely related to heightened oxidative insults and neuroinflammatory injury. Pinocembrin, a bioflavonoid, exhibits different biological functions, such as immunomodulatory, anti-inflammatory, antioxidative, and cerebroprotective activities. Herein, we examined the protective effects and molecular mechanisms of pinocembrin in a murine model of SAH. Using an endovascular perforation model in rats, pinocembrin significantly mitigated SAH-induced neuronal tissue damage, including inflammatory injury and free-radical insults. Meanwhile, pinocembrin improved behavior function and reduced neuronal apoptosis. We also revealed that sirtuin-1 (SIRT1) activation was significantly enhanced by pinocembrin. In addition, pinocembrin treatment evidently enhanced peroxisome proliferator-activated receptor-γ coactivator expression and suppressed ac-nuclear factor-kappa B levels. In contrast, EX-527, a selective SIRT1 inhibitor, blunted the protective effects of pinocembrin against SAH by suppressing SIRT1-mediated signaling. These results suggested that the cerebroprotective actions of pinocembrin after SAH were through SIRT1-dependent pathway, suggesting the potential application of pinocembrin for the treatment of SAH.

Subarachnoid hemorrhage (SAH) is an acute cerebral vascular disease featured by oxidative insults and neuroinflammation. Cycloastragenol (CAG), the major active component of Astragalus radix, has a wide range of biological functions. However, the potential beneficial effects and the underlying molecular mechanisms of CAG on SAH remain obscure. In the current study, the cerebroprotective effects and mechanism of CAG on SAH were evaluated both in vivo and in vitro. Our results indicated that CAG significantly suppressed SAH-triggered oxidative insults, inflammatory mediators production, microglia activation, and the neutrophil infiltration in the brain. In addition, CAG improved neurological function and ameliorated neuronal apoptosis and degeneration after SAH. In vitro results also revealed the therapeutic effects of CAG on neurons and microglia co-culture system. Mechanistically, CAG treatment upregulated sirtuin 1 (SIRT1) expression, inhibited the levels of FoxO1, nuclear factor-kappa B, and p53 acetylation, and suppressed the subsequent oxidative, inflammatory, and apoptotic pathways. In contrast, inhibiting SIRT1 by pretreatment with Ex527 abrogated the protective actions of CAG both in vivo and in vitro models of SAH. Collectively, our findings indicated that CAG could be a promising and effective drug candidate for SAH.

The work presented herein focuses on simulating the compounding process via a torque rheometer, as well as the relationship between the melt viscosity and the polymer molecular weight (MW). We aim to predict the plasticization of polylactic acid (PLA) using polypropylene glycol (PPG) with different MWs. The rheological properties of the PLA/PPG composites containing PPG with different MWs were systematically studied by capillary rheometry and torque rheometry. The initial degradation of PLA/PPG composites during melt processing was monitored in real time. The results indicate that PPG can significantly reduce the melt viscosity of PLA/PPG composites, leading to obvious pseudoplastic fluid behavior. The lower the MW of PPG, the lower the viscosity of the PLA/PPG composite. The addition of PPG was favorable for the degradation of PLA during processing, and the degradation degree of the composite materials increased as the MW of PPG was decreased.